In 2012, after the ATP1A3 gene discovery for Alternating Hemiplegia of Childhood was found, a symposium for ATP1A3-related diseases was begun. The symposium brings together prominent scientists, clinicians, and family foundations to:
- discuss the role of the ATP1A3 gene in rare neurological diseases.
- present further research progress on AHC, RDP, CA(P)OS, and other ATP1A3-related diseases.
- discuss various symptomology and how to address them to improve the quality of life for patients now and with respect to clinical trials.
- plan new research and include clinical teams in the ongoing work.
The AHCF is pleased to support the goals and objectives of the symposium by donating funds to offset the cost of the meeting as well as providing stipends to researchers or medical specialists from the United States.
Previous Meetings Include:
2012 Brussels, Belgium – Program
2013 Rome, Italy – Program
Meeting Summary by Dr. Albert George
2014 Lunteren, the Netherlands – Program
Meeting Summary by Dr. Albert George
2015 Bethesda, United States – Program
2016 London, England – Program
2017 Tokyo, Japan – Program
2018 Chicago, United States
2019 Reykjavik, Iceland – Program
Meeting Summary by Dr. Albert George
2021 Stockholm, Sweden – Program
2022 Edinburgh, Scotland – Program
2023 Chicago, United States
Meeting summary by Dr Albert George
2024 Barcelona, Spain
For any inquiries or further information on ATP1A3 meetings, contact: atp1a3disease@gmail.com
If you like to receive updated information on the ATP1A3disease Symposia, please provide: your name, affiliation, and email address
